Factors associated with chronic kidney disease among patients with hepatitis c infection attending Kigeme district

Japhet Ndatumuremyi1,2, Isaie Nshimiyimana3, Jean Pierre Sendegeya3

  • 1Catholic University of Rwanda, Huye, Rwanda. ndatumuremyi1985@gmail.com.

Scientific Reports
|January 13, 2026
PubMed

Insights

Chronic kidney disease (CKD) affects 12% of hepatitis C virus (HCV)-infected patients in Rwanda. Detectable HCV RNA, hypertension, diabetes, and older age are key risk factors for CKD in this population.

Area of Science:

  • Nephrology
  • Hepatology
  • Infectious Diseases

Background:

  • Chronic hepatitis C (HCV) affects millions globally and in Rwanda, posing risks beyond liver damage, including kidney injury.
  • Hepatitis C virus (HCV) can lead to chronic kidney disease (CKD) through immune complex deposition or direct viral effects.
  • Limited data exist on CKD prevalence and associated factors among HCV-infected individuals in Rwanda.

Purpose of the Study:

  • To determine the prevalence of chronic kidney disease (CKD) among hepatitis C virus (HCV)-infected patients receiving care at Kigeme District Hospital.
  • To explore demographic and clinical factors associated with CKD in this patient cohort.

Main Methods:

  • A cross-sectional study involving 225 HCV-seropositive patients selected via systematic random sampling.
  • Data abstraction from electronic patient files using Kobo Toolbox, followed by cleaning and analysis in STATA V15.
  • Modified Poisson regression was used to identify factors associated with CKD, with statistical significance set at p < 0.05.

Main Results:

  • The overall prevalence of CKD among the 225 participants was 12% (95% CI: 8.05-16.9).
  • CKD prevalence was higher in patients with detectable HCV RNA (18.57%).
  • Independent factors associated with CKD included detectable HCV RNA (aPR=2.10), hypertension (aPR=2.39), diabetes mellitus (aPR=2.88), and older age (aPR=2.73).

Conclusions:

  • Chronic kidney disease (CKD) is a significant comorbidity in hepatitis C virus (HCV)-infected individuals in Rwanda.
  • Both viral factors (HCV replication) and host factors (older age, hypertension, diabetes) contribute to CKD development.
  • Integrated screening and management of kidney function are crucial for high-risk HCV patients to prevent disease progression.

Related Concept Videos

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...